COX-2 inhibitors: increased risk of CV events?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 867卷 / 1期
关键词：
Celecoxib; Naproxen; Rofecoxib; Nabumetone; Adverse Event Reporting System;
D O I：
10.2165/00128415-200108670-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [21] Blood pressure effects of COX-2 inhibitors
    Krum, Henry
    Aw, Tai-Juan
    Liew, Danny
    Haas, Steven
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 : S43 - S48
  • [22] Hybrid fluorescent conjugates of COX-2 inhibitors: Search for a COX-2 isozyme imaging cancer biomarker
    Bhardwaj, Atul
    Kaur, Jatinder
    Sharma, Sai Kiran
    Huang, Zhangjian
    Wuest, Frank
    Knaus, Edward E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) : 163 - 168
  • [23] COX-2, NSAIDs, and cardiovascular risk
    McGettigan P.
    Henry D.
    Current Cardiovascular Risk Reports, 2007, 1 (4) : 296 - 302
  • [24] COX-2 Inhibitor and Non-Selective NSAID Use in Those at Increased Risk of NSAID-Related Adverse Events
    Gadzhanova, Svetla
    Ilomaeki, Jenni
    Roughead, Elizabeth E.
    DRUGS & AGING, 2013, 30 (01) : 23 - 30
  • [25] Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
    Jeffrey S Borer
    Lee S Simon
    Arthritis Research & Therapy, 7
  • [26] Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension
    Frank Ruschitzka
    Current Hypertension Reports, 2007, 9 : 41 - 44
  • [27] COX-2 Inhibitors and Gastric Cancer
    Wang, Zhen
    Chen, Jun-qiang
    Liu, Jin-lu
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [28] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
    Ashok, Varun
    Dash, Chiranjeev
    Rohan, Thomas E.
    Sprafka, J. Michael
    Terry, Paul D.
    BREAST, 2011, 20 (01) : 66 - 70
  • [29] Are selective COX-2 inhibitors nephrotoxic?
    Perazella, MA
    Eras, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 937 - 940
  • [30] Rofecoxib: A selective and effective COX-2 inhibitor
    不详
    Drugs & Therapy Perspectives, 2002, 18 (2) : 1 - 3
12345